You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 9, March 4, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Cardiovascular Interventions, Other
 •Cardiovascular System
 •Surgery
 •Surgical Interventions
 •Cardiovascular/ Cardiothoracic Surgery
 •Endocrine Surgery
 •Transplantation
 •Cardiac Transplantation
 •Kidney Transplantation
 •Liver Transplantation
 •Transplantation, Other
 •Gastroenterology
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Current Status of Xenotransplantation

Richard N. Pierson III, MD

JAMA. 2009;301(9):967-969.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Transplantation improves quality of life and saves tens of thousands of lives each year. However, the supply of human organs and tissues is insufficient to treat all patients who qualify for kidney, liver, islet cell, pancreas, heart, or lung transplantation. These considerations provide a powerful impetus motivating early clinical introduction of cross-species or xenotransplantation.

Pigs have been developed as a potential xenograft source species based on various physiological and logistical considerations.1 Use of nonhuman primates is not feasible for a number of reasons, ethical concerns prominent among them, and because the risk of a nonhuman primate virus causing epidemic human disease is not acceptable.2 Recently, a clinical islet xenograft trial involving 8 patients with diabetes and using porcine pancreatic cells has obtained provisional approval by New Zealand regulatory authorities.3 This Commentary discusses scientific benchmarks and ethical predicates necessary before clinical xenotransplant trials.

Organ-Specific Considerations

Heart and Kidney. . . [Full Text of this Article]

Author Affiliations: Department of Surgery, Baltimore Veterans Affairs Medical Center, and Division of Cardiac Surgery, University of Maryland, Baltimore.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.